α1-Adrenoceptor subtypes and lower urinary tract symptoms

Debra A. Schwinn, Claus Roehrborn

Research output: Contribution to journalArticle

125 Citations (Scopus)

Abstract

Benign prostatic hyperplasia (BPH) is a common cause of urinary outflow obstruction in aging men leading to lower urinary tract symptoms (LUTS). α1-Adrenoceptors (α1ARs) antagonists (blockers) have become a mainstay of LUTS treatment because they relax prostate smooth muscle and decrease urethral resistance, as well as relieving bladder LUTS symptoms. A review of key recent clinical trials suggests new insights into the role of specific α1AR subtypes in the treatment of LUTS.

Original languageEnglish (US)
Pages (from-to)193-199
Number of pages7
JournalInternational Journal of Urology
Volume15
Issue number3
DOIs
StatePublished - Mar 2008

Fingerprint

Lower Urinary Tract Symptoms
Adrenergic Receptors
Prostatic Hyperplasia
Smooth Muscle
Prostate
Urinary Bladder
Clinical Trials
Therapeutics

Keywords

  • Adrenergic
  • Adrenoceptor
  • Alpha blockers
  • Benign prostatic hyperplasia
  • BPH
  • Prostate

ASJC Scopus subject areas

  • Urology
  • Medicine(all)

Cite this

α1-Adrenoceptor subtypes and lower urinary tract symptoms. / Schwinn, Debra A.; Roehrborn, Claus.

In: International Journal of Urology, Vol. 15, No. 3, 03.2008, p. 193-199.

Research output: Contribution to journalArticle

@article{90933c3faa4e441da1971548dc6a46c4,
title = "α1-Adrenoceptor subtypes and lower urinary tract symptoms",
abstract = "Benign prostatic hyperplasia (BPH) is a common cause of urinary outflow obstruction in aging men leading to lower urinary tract symptoms (LUTS). α1-Adrenoceptors (α1ARs) antagonists (blockers) have become a mainstay of LUTS treatment because they relax prostate smooth muscle and decrease urethral resistance, as well as relieving bladder LUTS symptoms. A review of key recent clinical trials suggests new insights into the role of specific α1AR subtypes in the treatment of LUTS.",
keywords = "Adrenergic, Adrenoceptor, Alpha blockers, Benign prostatic hyperplasia, BPH, Prostate",
author = "Schwinn, {Debra A.} and Claus Roehrborn",
year = "2008",
month = "3",
doi = "10.1111/j.1442-2042.2007.01956.x",
language = "English (US)",
volume = "15",
pages = "193--199",
journal = "International Journal of Urology",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - α1-Adrenoceptor subtypes and lower urinary tract symptoms

AU - Schwinn, Debra A.

AU - Roehrborn, Claus

PY - 2008/3

Y1 - 2008/3

N2 - Benign prostatic hyperplasia (BPH) is a common cause of urinary outflow obstruction in aging men leading to lower urinary tract symptoms (LUTS). α1-Adrenoceptors (α1ARs) antagonists (blockers) have become a mainstay of LUTS treatment because they relax prostate smooth muscle and decrease urethral resistance, as well as relieving bladder LUTS symptoms. A review of key recent clinical trials suggests new insights into the role of specific α1AR subtypes in the treatment of LUTS.

AB - Benign prostatic hyperplasia (BPH) is a common cause of urinary outflow obstruction in aging men leading to lower urinary tract symptoms (LUTS). α1-Adrenoceptors (α1ARs) antagonists (blockers) have become a mainstay of LUTS treatment because they relax prostate smooth muscle and decrease urethral resistance, as well as relieving bladder LUTS symptoms. A review of key recent clinical trials suggests new insights into the role of specific α1AR subtypes in the treatment of LUTS.

KW - Adrenergic

KW - Adrenoceptor

KW - Alpha blockers

KW - Benign prostatic hyperplasia

KW - BPH

KW - Prostate

UR - http://www.scopus.com/inward/record.url?scp=39849096422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39849096422&partnerID=8YFLogxK

U2 - 10.1111/j.1442-2042.2007.01956.x

DO - 10.1111/j.1442-2042.2007.01956.x

M3 - Article

C2 - 18304211

AN - SCOPUS:39849096422

VL - 15

SP - 193

EP - 199

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - 3

ER -